Monthly revenue YoY ≥ 20% (from filing deadline)
Active · now 41.27%Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).
Copy the prompt to get recent events, historical reactions, and a short research brief.
Tell your AI:
Help me set up FinLab and analyze 7743 金利食安. Please read: https://finlab.finance/en/setup?stock=7743
quality needs a look, fair valuation.
Weak profitability.Operating margin is in the 28th market percentile. Latest quarterly ROE ≈ 0.2%.
Valuation is neutral.PE is in the 70th market percentile.
Foreign investors are net selling.Foreign 20-day net flow ≈ -1.4% of volume (net sell).
Strong revenue growth.Latest monthly revenue YoY ≈ 41.3%, above the 20% growth threshold.
Signals are active now.On the latest data, signals such as Revenue YoY ≥ 20% are active — see the historical forward returns after each occurrence below.
Institutional rotation, concentration steady — bullish
Window from 2026-01-17 · Price -2% · branches to 2026-06-17· TDCC to 2026-06-12
Weak direction: big-holder share fell while retail share rose.
Describes chip flow, not investment advice. Branch data discloses only high-volume branches with ~1-day lag; TDCC is weekly. Inventory is a relative reconstruction from the window start, not absolute holdings.
These signals are true on the latest data, with this stock's own historical forward-return stats after each occurrence.
Monthly revenue YoY ≥ 20%; event date is the first trading day after the filing deadline (no look-ahead).
Over the past 242 months, on average ~404 stocks per month met “monthly revenue YoY ≥ 20%”; their adjusted-close return over the next 60 trading days averaged 6.94% (equal-weighted), beating the market by 2.37 points on average, and outperformed the TAIEX total-return index in 64.5% of months.
Each month, equal-weighted 60-day forward adjusted return of all signal-matching stocks, then averaged across months; excess vs the TAIEX total-return index.
These are not occurring now; historical samples shown for comparison.
Adjusted close makes a new 252-day high; repeats within 20 days counted once.
Foreign net flow (ex-dealer) positive for 5 straight days; event on day 5; repeats within 20 days counted once.
金利食安科技股份有限公司成立於2011年6月9日,總部位於屏東縣屏東市前進里園西街15號,統一編號53414676。公司於2025年5月20日上櫃,證券種類為普通股。董事長為廖日興,總經理為殷豪。公開資訊與櫃買中心資料顯示,公司主要業務為從事蔬果汁及機能飲品等運用HPP技術之產品研發、製造及銷售;實收資本額約新台幣364,833,380元,發行股數36,483,338股。員工規模不同來源略有差異:104人力銀行列約150人,台灣就業通列119人,經理人報導列約130人,故以約120至150人區間看待。公司沿革重點包括2012年屏東一廠落成並引進第一台HPP超高壓低溫滅菌設備,2013年取得HPP HACCP與ISO 22000,2015年成立冷壓蔬果汁專業食品廠,2016年取得FSSC 22000,2021年引進第二台HPP設備並成立冷壓蔬果汁第二條產線,2023年屏東二廠落成。公司100%持有食安生技股份有限公司,負責自有品牌商品銷售及行銷;另設GLOWING ENERGY LIMITED負責海外市場銷售。年報揭露之法人董事主要股東資料顯示,法人股東倍利麗稘股份有限公司之主要股東為廖日興42%、廖儀馨15%、廖儀君15%、廖薽稘15%、蔡麗英13%;此為2024年4月30日資料,非2026年最新股東名冊。
金利食安是以HPP(High Pressure Processing,高壓低溫殺菌/加工)為核心技術的食品加工廠,主要產品包括冷壓蔬果汁、機能性飲品、鱸魚精、RTC/RTE即烹即食產品、醬料、果塊果丁,以及食品同業HPP低溫殺菌代工服務。自有品牌包括「純在」冷壓蔬果汁、「品純萃」機能產品,另有冷萃茶等品項;商業模式為自有品牌零售通路銷售、ODM/OEM代工、B2B餐飲與航空客戶供應並行。2023年營收結構為冷壓蔬果汁5.27354億元、占91.40%;其他HPP產品3,345.3萬元、占5.80%;其他1,615.8萬元、占2.80%。2024年營收6.42億元,毛利率33.26%,稅後純益6,171萬元,EPS 1.85元;2025年營收約6.82億元,毛利率約28.5%,EPS約0.57元,獲利明顯低於2024年,主因可能包含海外布局與上櫃相關費用、匯損及成本壓力。2026年第1季營收1.54076億元、EPS 0.05元;2026年前5月營收約3.12億元,其中5月營收7,762.9萬元、年增41.27%。銷售地區方面,2023年內銷占80.10%,外銷占19.90%,其中日本7.24%、美國11.95%、其他0.71%;相較2021至2022年外銷占比約3.83%至5.03%,外銷比重已有提升。年報揭露2023年A客戶占50.97%、B客戶占11.95%、C客戶占5.86%,客戶集中度高,但實名未揭露;公開新聞另提及產品獲華航、長榮航、星宇航空採用,並有好市多等大型通路銷售。
2025至2028年主要成長動能包括:一、冷壓蔬果汁自有品牌「純在」在零售、量販與便利通路擴張;二、HPP ODM代工訂單增加,特別是肉品、海鮮、非熱殺菌食品及餐飲原料;三、機能性飲品「品純萃」延伸至術後復原、銀髮族與醫療機能市場;四、產品線從蔬果汁延伸到冷萃飲品、冷壓氣泡飲、益生菌蔬果飲、植物基蛋白飲、機能SHOT、嬰兒副食品、即食醬料、無添加調味或冷凍水產品;五、外銷市場擴張,美國、加拿大、澳洲、韓國、中國及歐洲為公司公開提及的方向,並規劃以東協、泰國等基地降低關稅與物流成本;六、2023年二廠落成與新設備投資,有助於產能、品項與B2B接單彈性。產業趨勢上,消費者對無添加、低糖、健康、新鮮、食安可追溯及高齡營養產品的需求,有利HPP技術滲透率提高。主要挑戰包括:HPP設備與冷鏈成本高,產品售價較高導致目標客群偏中高階;果物、蔗糖、包材、人力、冷鏈及能源成本波動;外銷提高後面臨匯率與海外通路費用;A客戶占比偏高導致客戶集中風險;冷壓果汁與健康飲料市場已有國際品牌與在地中小品牌競爭;食品法規、標示、微生物檢驗與召回風險高;2025獲利下滑顯示營收成長未必同步轉化為淨利。2027至2028展望屬推估:若外銷與B2B餐飲/航空/量販客戶穩定放量,且公司能維持毛利率與費用率,營收仍有成長空間;但若匯率、促銷費用、海外開拓費用或原料成本壓力延續,獲利恢復速度可能慢於營收。
This company profile is compiled from public sources (annual reports, filings, news and analyst reports), not finlab backtest data; the 2025–2028 outlook contains forward-looking estimates and is for reference only.
This page is historical statistics for educational purposes and is not investment advice. Investing involves risk; past performance does not indicate future results. Assess and bear the risk yourself before trading.